Phase I trial of dihydrolenperone in lung cancer patients: A novel compound within vitro activity against lung cancer

Phase I trial of dihydrolenperone in lung cancer patients: A novel compound within vitro activity against lung cancer

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Investigational new drugs 1993-02, Vol.11 (1), p.29-37
Hauptverfasser: Johnson, Bruce E., Parker, Robert, Tsai, C. M., Baltz, Julie, Miller, Mae Jean, Shoemaker, Robert, Phelps, Ruby, Bastian, Anne, Stocker, Joyce, Phares, John, Mulshine, James L., Gazdar, Adi F., Ihde, Daniel C.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 37
container_issue 1
container_start_page 29
container_title Investigational new drugs
container_volume 11
creator Johnson, Bruce E.
Parker, Robert
Tsai, C. M.
Baltz, Julie
Miller, Mae Jean
Shoemaker, Robert
Phelps, Ruby
Bastian, Anne
Stocker, Joyce
Phares, John
Mulshine, James L.
Gazdar, Adi F.
Ihde, Daniel C.
description
doi_str_mv 10.1007/BF00873907
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF00873907</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1007_BF00873907</sourcerecordid><originalsourceid>FETCH-LOGICAL-c767-973074d5c16b429855b18d0234cab6e5a8f951fa9c74c8e7c5eadb6c6a0465253</originalsourceid><addsrcrecordid>eNpNkMFKAzEURYMoWKsbvyBrYfRlMkkm7mqxWijoovvhTSbTRqbJkKSV_r0VBV3du7gcLoeQWwb3DEA9PC0AasU1qDMyYULxAmQlz8kEmFSF1FpdkquUPgCAa1VNyP59i8nSJc3R4UBDTzu3PXYxDNaPNgZvqfN02PsNNeiNjXTE7KzP6ZHOqA8HO1ATdmPY-45-urw9rQ8ux0DRZHdqR4obdD7l_5BrctHjkOzNb07JevG8nr8Wq7eX5Xy2Kow63dWKg6o6YZhsq1LXQrSs7qDklcFWWoF1rwXrURtVmdoqIyx2rTQSoZKiFHxK7n6wJoaUou2bMbodxmPDoPn21fz54l_tGl7H</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Phase I trial of dihydrolenperone in lung cancer patients: A novel compound within vitro activity against lung cancer</title><source>SpringerLink Journals - AutoHoldings</source><creator>Johnson, Bruce E. ; Parker, Robert ; Tsai, C. M. ; Baltz, Julie ; Miller, Mae Jean ; Shoemaker, Robert ; Phelps, Ruby ; Bastian, Anne ; Stocker, Joyce ; Phares, John ; Mulshine, James L. ; Gazdar, Adi F. ; Ihde, Daniel C.</creator><creatorcontrib>Johnson, Bruce E. ; Parker, Robert ; Tsai, C. M. ; Baltz, Julie ; Miller, Mae Jean ; Shoemaker, Robert ; Phelps, Ruby ; Bastian, Anne ; Stocker, Joyce ; Phares, John ; Mulshine, James L. ; Gazdar, Adi F. ; Ihde, Daniel C.</creatorcontrib><identifier>ISSN: 0167-6997</identifier><identifier>EISSN: 1573-0646</identifier><identifier>DOI: 10.1007/BF00873907</identifier><language>eng</language><ispartof>Investigational new drugs, 1993-02, Vol.11 (1), p.29-37</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c767-973074d5c16b429855b18d0234cab6e5a8f951fa9c74c8e7c5eadb6c6a0465253</citedby><cites>FETCH-LOGICAL-c767-973074d5c16b429855b18d0234cab6e5a8f951fa9c74c8e7c5eadb6c6a0465253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Johnson, Bruce E.</creatorcontrib><creatorcontrib>Parker, Robert</creatorcontrib><creatorcontrib>Tsai, C. M.</creatorcontrib><creatorcontrib>Baltz, Julie</creatorcontrib><creatorcontrib>Miller, Mae Jean</creatorcontrib><creatorcontrib>Shoemaker, Robert</creatorcontrib><creatorcontrib>Phelps, Ruby</creatorcontrib><creatorcontrib>Bastian, Anne</creatorcontrib><creatorcontrib>Stocker, Joyce</creatorcontrib><creatorcontrib>Phares, John</creatorcontrib><creatorcontrib>Mulshine, James L.</creatorcontrib><creatorcontrib>Gazdar, Adi F.</creatorcontrib><creatorcontrib>Ihde, Daniel C.</creatorcontrib><title>Phase I trial of dihydrolenperone in lung cancer patients: A novel compound within vitro activity against lung cancer</title><title>Investigational new drugs</title><issn>0167-6997</issn><issn>1573-0646</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><recordid>eNpNkMFKAzEURYMoWKsbvyBrYfRlMkkm7mqxWijoovvhTSbTRqbJkKSV_r0VBV3du7gcLoeQWwb3DEA9PC0AasU1qDMyYULxAmQlz8kEmFSF1FpdkquUPgCAa1VNyP59i8nSJc3R4UBDTzu3PXYxDNaPNgZvqfN02PsNNeiNjXTE7KzP6ZHOqA8HO1ATdmPY-45-urw9rQ8ux0DRZHdqR4obdD7l_5BrctHjkOzNb07JevG8nr8Wq7eX5Xy2Kow63dWKg6o6YZhsq1LXQrSs7qDklcFWWoF1rwXrURtVmdoqIyx2rTQSoZKiFHxK7n6wJoaUou2bMbodxmPDoPn21fz54l_tGl7H</recordid><startdate>199302</startdate><enddate>199302</enddate><creator>Johnson, Bruce E.</creator><creator>Parker, Robert</creator><creator>Tsai, C. M.</creator><creator>Baltz, Julie</creator><creator>Miller, Mae Jean</creator><creator>Shoemaker, Robert</creator><creator>Phelps, Ruby</creator><creator>Bastian, Anne</creator><creator>Stocker, Joyce</creator><creator>Phares, John</creator><creator>Mulshine, James L.</creator><creator>Gazdar, Adi F.</creator><creator>Ihde, Daniel C.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>199302</creationdate><title>Phase I trial of dihydrolenperone in lung cancer patients: A novel compound within vitro activity against lung cancer</title><author>Johnson, Bruce E. ; Parker, Robert ; Tsai, C. M. ; Baltz, Julie ; Miller, Mae Jean ; Shoemaker, Robert ; Phelps, Ruby ; Bastian, Anne ; Stocker, Joyce ; Phares, John ; Mulshine, James L. ; Gazdar, Adi F. ; Ihde, Daniel C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c767-973074d5c16b429855b18d0234cab6e5a8f951fa9c74c8e7c5eadb6c6a0465253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Johnson, Bruce E.</creatorcontrib><creatorcontrib>Parker, Robert</creatorcontrib><creatorcontrib>Tsai, C. M.</creatorcontrib><creatorcontrib>Baltz, Julie</creatorcontrib><creatorcontrib>Miller, Mae Jean</creatorcontrib><creatorcontrib>Shoemaker, Robert</creatorcontrib><creatorcontrib>Phelps, Ruby</creatorcontrib><creatorcontrib>Bastian, Anne</creatorcontrib><creatorcontrib>Stocker, Joyce</creatorcontrib><creatorcontrib>Phares, John</creatorcontrib><creatorcontrib>Mulshine, James L.</creatorcontrib><creatorcontrib>Gazdar, Adi F.</creatorcontrib><creatorcontrib>Ihde, Daniel C.</creatorcontrib><collection>CrossRef</collection><jtitle>Investigational new drugs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Johnson, Bruce E.</au><au>Parker, Robert</au><au>Tsai, C. M.</au><au>Baltz, Julie</au><au>Miller, Mae Jean</au><au>Shoemaker, Robert</au><au>Phelps, Ruby</au><au>Bastian, Anne</au><au>Stocker, Joyce</au><au>Phares, John</au><au>Mulshine, James L.</au><au>Gazdar, Adi F.</au><au>Ihde, Daniel C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phase I trial of dihydrolenperone in lung cancer patients: A novel compound within vitro activity against lung cancer</atitle><jtitle>Investigational new drugs</jtitle><date>1993-02</date><risdate>1993</risdate><volume>11</volume><issue>1</issue><spage>29</spage><epage>37</epage><pages>29-37</pages><issn>0167-6997</issn><eissn>1573-0646</eissn><doi>10.1007/BF00873907</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0167-6997
ispartof Investigational new drugs, 1993-02, Vol.11 (1), p.29-37
issn 0167-6997
1573-0646
language eng
recordid cdi_crossref_primary_10_1007_BF00873907
source SpringerLink Journals - AutoHoldings
title Phase I trial of dihydrolenperone in lung cancer patients: A novel compound within vitro activity against lung cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T10%3A01%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phase%20I%20trial%20of%20dihydrolenperone%20in%20lung%20cancer%20patients:%20A%20novel%20compound%20within%20vitro%20activity%20against%20lung%20cancer&rft.jtitle=Investigational%20new%20drugs&rft.au=Johnson,%20Bruce%20E.&rft.date=1993-02&rft.volume=11&rft.issue=1&rft.spage=29&rft.epage=37&rft.pages=29-37&rft.issn=0167-6997&rft.eissn=1573-0646&rft_id=info:doi/10.1007/BF00873907&rft_dat=%3Ccrossref%3E10_1007_BF00873907%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true